This inventor holds 17 USPTO granted patents, primarily in Chemical Derivatives. Top assignees: Hoffmann-La Roche Inc., Ciba-Geigy Corporation. Active years: 1978-1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1978-1987
Areas of Expertise:
Title: The Innovations of Rudolf Pfister - A Pioneer in Pharmacological Patents
Introduction
Rudolf Pfister, an accomplished inventor based in Basel, Switzerland, has made significant contributions to the field of pharmaceuticals through his innovative inventions. With a remarkable portfolio of 17 patents, Pfister's work primarily focuses on compounds with therapeutic properties, particularly in addressing allergic reactions and inflammatory conditions.
Latest Patents
Among his latest patents is a compound known as derivatives of 10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-ethanol, specifically 1-[2-(4,5,10,11-Tetrahydro-1H-dibenzo[a,d]cyclohepten-5-yl)ethyl]pyrrolidine and its pharmaceutically acceptable acid addition salts. These compounds have demonstrated valuable histamine-H1 antagonistic properties, making them suitable for controlling or preventing allergic reactions such as urticaria, hay fever, anaphylaxis, and over-sensitivity to medications.
Additionally, Pfister has developed another patent for a compound known as 4-Hydroxy-2-methyl-3-(2-pyridylcarbamoyl)-6-trifluoromethyl-2H-thieno[2,3-e]-1,2-thiazine 1,1-dioxide and its pharmaceutically acceptable salts. These compounds have showcased significant pharmacodynamic properties, particularly anti-inflammatory, analgesic, and antirheumatic activities, and can be synthesized by reacting a corresponding alkyl ester with 2-aminopyridine, followed by optional salt formation.
Career Highlights
Rudolf Pfister's career spans notable tenures at prominent companies, including Hoffmann-La Roche Inc. and Ciba-Geigy Corporation. His work at these organizations has been instrumental in advancing pharmaceutical research and development, culminating in a plethora of patents that address critical health issues.
Collaborations
Throughout his career, Pfister has collaborated with esteemed colleagues such as Paul Zeller and Dieter Binder. These partnerships have further fueled innovation and contributed to the development of groundbreaking therapeutic compounds.
Conclusion
Rudolf Pfister stands out as a key figure in the realm of pharmaceutical inventions. His work has not only advanced scientific knowledge but also provided invaluable solutions for patients suffering from various ailments. With continued dedication to research and innovation, Pfister's contributions will undoubtedly leave a lasting impact on the field of pharmacology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile